Mandy Elizabeth Mary Turner, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 8 | 2024 | 2254 | 1.580 |
Why?
|
| Phosphates | 7 | 2024 | 763 | 1.420 |
Why?
|
| Hyperphosphatemia | 1 | 2024 | 38 | 0.890 |
Why?
|
| Calcitriol | 2 | 2022 | 295 | 0.870 |
Why?
|
| Minerals | 2 | 2023 | 283 | 0.840 |
Why?
|
| Vitamin K | 3 | 2023 | 313 | 0.700 |
Why?
|
| Calcinosis | 4 | 2024 | 1477 | 0.700 |
Why?
|
| Vitamin K Deficiency | 1 | 2018 | 24 | 0.620 |
Why?
|
| Calcium | 5 | 2024 | 5720 | 0.590 |
Why?
|
| Glomerular Filtration Rate | 4 | 2021 | 2181 | 0.590 |
Why?
|
| Iohexol | 1 | 2017 | 205 | 0.530 |
Why?
|
| Kidney | 2 | 2021 | 7034 | 0.460 |
Why?
|
| Vitamin D Deficiency | 1 | 2022 | 1388 | 0.410 |
Why?
|
| Cardiovascular Diseases | 4 | 2024 | 15513 | 0.400 |
Why?
|
| Phosphoproteins | 1 | 2021 | 2443 | 0.390 |
Why?
|
| Warfarin | 1 | 2020 | 1482 | 0.380 |
Why?
|
| Metabolome | 1 | 2018 | 989 | 0.380 |
Why?
|
| Parathyroid Hormone | 4 | 2024 | 1803 | 0.370 |
Why?
|
| Kidney Failure, Chronic | 1 | 2022 | 2478 | 0.340 |
Why?
|
| Chromatography, Liquid | 2 | 2022 | 982 | 0.310 |
Why?
|
| Calcium, Dietary | 2 | 2023 | 529 | 0.310 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2022 | 1186 | 0.260 |
Why?
|
| Rats | 5 | 2023 | 23713 | 0.260 |
Why?
|
| Proteins | 2 | 2024 | 5993 | 0.240 |
Why?
|
| Polycarboxylate Cement | 1 | 2024 | 18 | 0.230 |
Why?
|
| Contrast Media | 1 | 2017 | 5311 | 0.220 |
Why?
|
| Homeostasis | 2 | 2023 | 3318 | 0.200 |
Why?
|
| Inulin | 2 | 2020 | 67 | 0.190 |
Why?
|
| Aortic Valve Stenosis | 2 | 2024 | 2018 | 0.180 |
Why?
|
| Canada | 3 | 2021 | 2125 | 0.180 |
Why?
|
| Receptors, Calcitriol | 1 | 2022 | 360 | 0.170 |
Why?
|
| Vitamin D | 3 | 2022 | 3302 | 0.170 |
Why?
|
| Hormones | 1 | 2024 | 869 | 0.170 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 26068 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2018 | 8164 | 0.150 |
Why?
|
| Inflammasomes | 1 | 2023 | 525 | 0.150 |
Why?
|
| Aorta, Abdominal | 2 | 2019 | 625 | 0.150 |
Why?
|
| Lipoprotein(a) | 1 | 2022 | 482 | 0.140 |
Why?
|
| Aortic Valve | 2 | 2024 | 1959 | 0.140 |
Why?
|
| Metabolic Clearance Rate | 1 | 2017 | 362 | 0.140 |
Why?
|
| Sex Characteristics | 2 | 2023 | 2638 | 0.120 |
Why?
|
| Inflammation | 3 | 2023 | 10758 | 0.120 |
Why?
|
| Animals | 7 | 2023 | 168083 | 0.120 |
Why?
|
| Vitamins | 1 | 2022 | 1634 | 0.110 |
Why?
|
| Humans | 20 | 2024 | 761098 | 0.110 |
Why?
|
| Proteomics | 2 | 2024 | 3836 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2020 | 1650 | 0.110 |
Why?
|
| Testosterone | 1 | 2024 | 2472 | 0.110 |
Why?
|
| Fibroblast Growth Factors | 1 | 2017 | 863 | 0.100 |
Why?
|
| Peripheral Arterial Disease | 1 | 2023 | 1274 | 0.100 |
Why?
|
| Osteoporosis | 2 | 2019 | 1604 | 0.090 |
Why?
|
| Feces | 1 | 2017 | 1490 | 0.090 |
Why?
|
| Macrophages | 2 | 2023 | 5754 | 0.090 |
Why?
|
| Immunity, Innate | 1 | 2022 | 3044 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2017 | 4014 | 0.080 |
Why?
|
| Bone Density | 2 | 2019 | 3548 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2023 | 3758 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2023 | 3405 | 0.070 |
Why?
|
| Male | 11 | 2024 | 360675 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2019 | 3410 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2020 | 4795 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3245 | 0.050 |
Why?
|
| Vitamin K 2 | 1 | 2023 | 47 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 6504 | 0.050 |
Why?
|
| Vitamin K 1 | 1 | 2023 | 47 | 0.050 |
Why?
|
| Osteocalcin | 1 | 2023 | 274 | 0.050 |
Why?
|
| Obesity | 1 | 2023 | 12937 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2022 | 24013 | 0.050 |
Why?
|
| Middle Aged | 4 | 2024 | 220835 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2023 | 829 | 0.040 |
Why?
|
| Female | 6 | 2023 | 392458 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2023 | 1066 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2024 | 18926 | 0.040 |
Why?
|
| Water | 1 | 2024 | 1410 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 1002 | 0.040 |
Why?
|
| Polymers | 1 | 2024 | 1617 | 0.030 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2019 | 396 | 0.030 |
Why?
|
| Young Adult | 1 | 2023 | 59199 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 39953 | 0.030 |
Why?
|
| Aged | 4 | 2022 | 169266 | 0.030 |
Why?
|
| Risk Factors | 2 | 2022 | 74219 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2019 | 1381 | 0.030 |
Why?
|
| Proteome | 1 | 2024 | 1856 | 0.030 |
Why?
|
| Observer Variation | 1 | 2019 | 2611 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2023 | 1796 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 1005 | 0.030 |
Why?
|
| Disease Progression | 2 | 2020 | 13506 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2022 | 54419 | 0.020 |
Why?
|
| Demography | 1 | 2017 | 1643 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 4340 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 2892 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8639 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2019 | 2092 | 0.020 |
Why?
|
| Overweight | 1 | 2019 | 2418 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5869 | 0.020 |
Why?
|
| Myocardium | 1 | 2018 | 4746 | 0.020 |
Why?
|
| Comorbidity | 1 | 2019 | 10514 | 0.020 |
Why?
|
| Adult | 3 | 2024 | 221083 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 12058 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 4947 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18385 | 0.010 |
Why?
|
| Smoking | 1 | 2019 | 9055 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 9001 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18217 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39121 | 0.010 |
Why?
|